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Abstract 
Methicillin-resistant Staphylococcus aureus (MRSA), showing resistance to several antibiotics is a 
global health problem associated with considerable mortality and morbidity. Antibiotic 
susceptibility test is a commonly used method to characterize MRSA in epidemiologic studies. 
Additionally, plasmid profile has been reported to be useful in tracing the epidemiology of 
antibiotic resistance. This research was conducted to determine the antimicrobial resistance 
patterns and plasmid profiles of MRSA isolated from clinical samples at KIST Medical College, 
Imadol, Kathmandu, Nepal. All the clinical specimens sent to the laboratory were processed by 
standard microbiological techniques and antibiotic susceptibility testing was done by the modified 
Kirby Bauer disc diffusion method. Further, plasmid profiling was done by Alkaline-lysis method. 
A total of 27 (38.02%) MRSA were isolated from 71 S. aureus positive samples. MRSA showed the 
highest resistance towards penicillin (92.60%) and ampicillin (92.60%). In contrast, high levels of 
sensitivity were shown towards vancomycin (85.19%) and tetracycline (85.19%). Out of 27 MRSA 
positive samples, single plasmids were isolated from only 6 (22.22%) MRSA isolates. Antibiograms 
alone are inadequate to accomplish the characterization of MRSA during epidemiological studies. 
However, plasmid profile analysis in conjunction with the antibiotic susceptibility pattern is 
valuable in the epidemiological investigation of MRSA, and for reducing MRSA prevalence and 
treatment cost. 
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Introduction 
Methicillin-resistant Staphylococcus aureus 
(MRSA) was first reported in 1961, within a year 
of methicillin introduction [1]. Since then, 
MRSA strains have spread among hospitals and 
disseminated worldwide. Being recognized as a 
prominent nosocomial pathogen, in the past few 
decades MRSA has emerged outside of 
healthcare settings, spreading in the community 
[2, 3]. These community-associated MRSA 
strains have also been shown to be the cause of 
healthcare-associated infections [4]. Due to an 
increase in MRSA infection, the rate of 
morbidity and mortality has increased along 
with the increase in health care costs. 
In various countries, the prevalence of MRSA 
has varied from hospital to hospital. Indeed, 
Asia accounts for the highest prevalence rates of 
healthcare-associated methicillin-resistant S. 
aureus (HA-MRSA) and community-associated 
methicillin-resistant S. aureus (CA-MRSA) in the 
world. The Majority of hospitals in Asia are 
endemic for multidrug-resistant MRSA (MDR-
MRSA), with an estimated proportion of 28% (in 
Hong Kong and Indonesia) to >70% (in Korea) 
among all clinical S. aureus isolates in the early 
2010s [5]. In the United States, MRSA infection 
is the second major cause of death among people 
after AIDS per year and is estimated to cause 
more infections than the other diseases 
combined [6]. In large United States hospitals 
(500 or more beds), about 40% of S. aureus 
infections are methicillin-resistant and are 
increasing continuously [7]. In the context of 
Nepal, various research and studies showed 
great variations in the prevalence of MRSA 
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ranging from 11-50% [8-13]. Overuse or misuse 
of antibiotics may be the common reason for the 
rapid increase in the frequency of MRSA strains 
as well as MDR-MRSA [14]. Lack of hygienic 
practices of the medical personnel in hospitals 
or health care centers and lack of isolation room 
for the known patients already infected with 
MRSA strains in health care centers, etc. are the 
other probable reasons for the increase in MRSA 
infections [15]. 
The best understood mobile genetic elements 
are plasmids, which have been widely studied 
in epidemiological surveillance of MRSA 
outbreaks and in tracing antibiotic resistance 
[16]. It is currently suggested that more than 
90% of MRSA strains carry plasmids while 
numerous studies have supported that the 
genetic exchange of plasmids containing 
antibiotic-resistant genes between bacteria plays 
an important role in the evolution of multidrug-
resistance [17-19]. In various epidemiological 
studies, antibiograms and plasmid profiles are 
commonly used to characterize MRSA. 
However, to achieve differentiation, 
antibiograms are frequently inadequate. 
Plasmid profile is more instructive and has been 
reported to be a useful tool in tracing the 
epidemiology of antibiotic resistance. This study 
was therefore, conducted to analyze the 
discriminatory power of plasmid profile 
analysis in conjunction with antibiogram in 
differentiating different strains of MRSA and 
antibiotic resistance patterns and resistance 
plasmids of MRSA isolated from clinical 
samples.  
Materials and Methods 
This cross-sectional study was conducted at 
KIST Medical College, Imadol, Kathmandu, 
Nepal, from May 2014 to November 2014. The 
study comprises 2044 clinically ill, both indoor 
and outdoor patients which include children, 
adult and old of both sexes, aged between one 
month to ninety years who visited KIST Medical 
College, Imadol, Kathmandu. All the clinical 
specimens such as pus, urine, blood, sputum 
and body fluids were collected in strictly sterile, 
leak-proof, dry containers which were free from 
all traces of disinfectants. The sample specimens 
were collected by medical officers or as per the 
instruction by the medical officers before the use 
of antibiotics, and then immediately transferred 
to microbiology laboratory. The samples taken 
to the laboratory were processed as quickly as 
possible. Staphylococci obtained from different 
clinical specimens were studied for 
antimicrobial sensitivity pattern, and the MRSA 
obtained were subjected to plasmid profiling by 
the Alkaline-lysis method. The identification of 
the organism was based on standard laboratory 
criteria (growth in blood agar and McConkey 
agar media for 24-48 hours at 37°C, colonial 
morphology, Gram staining, catalase test, 
oxidase test, and coagulase test) [20]. After 
differentiation based on coagulase, the isolates 
were examined for the antimicrobial sensitivity 
pattern. The organisms were screened for MRSA 
using cefoxitin disc diffusion test. The Plasmid 
profile of MRSA was done by alkaline lysis 
method in Central Department of Microbiology, 
T.U., Kirtipur, Nepal. 
Isolation of bacterial plasmid DNA by 
Alkaline-SDS Lysis  
Plasmid DNA was isolated from MRSA 
according to Sambrook & Russel [21]. MRSA 
isolates were sub-cultured in Luria-Bertani 
broth at 37oC and 3 ml of the overnight culture 
was subjected to plasmid DNA extraction by 
centrifugation at 5000 rpm for 5 min. After 
washing in Tris-ethylene diamine tetraacetic 
acid (EDTA) buffer (10mM Tris, 1mM EDTA, 
pH 8.0, TE), the pellet was added to the freshly 
prepared mixture of NaOH and SDS (1:1), to 
which potassium acetate was added. The 
microfuge tube was inversely mixed and 
centrifuged at 13,000 rpm for 10 minutes. The 
supernatant was transferred into a new 
microfuge tube with adding Phenol: 
Chloroform (1:1) and centrifuged at 13,000 rpm 
for 10 minutes. The upper aqueous phase was 
collected in a clean microfuge tube to which 
Chloroform was added and centrifuged at 
13,000 rpm for 10 minutes. The supernatant was 
then transferred into a new microfuge tube and 
cold 95% ethanol was added to precipitate 
bacterial DNA. The pellet was washed with 70% 
ethanol and dissolved in 50 µl of TE buffer.  
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Table 1: Staphylococcal growth from various clinical specimens. Staphylococci were isolated from 
different clinical samples following standard microbiological techniques. The staphylococcal isolates 
were screened for S. aureus and CoNS by the coagulase test. S. aureus, Staphylococcus aureus; CoNS, 
coagulase-negative S. aureus. 
Type of 
organism 
Types of clinical sample 










S. aureus 23 (32.4) 16 (22.5) 5 (7) 22 (31) 5 (7) 71 
CoNS 14 (51.9) 9 (33.3) 1 (3.7) 3 (11.1) 0 27 
Total 37 (37.8) 25 (25.5) 6 (6.1) 25 (25.5) 5 (5.1) 98 
 
Preparation of agarose gel 
Agarose gel of 1 percent was prepared by 
melting 1 gm agarose in 100 ml of diluted TAE 
buffer using a microwave oven. The molten 
agarose was allowed to cool to about 50ºC and 
50 µl ethidium  bromide (1 mg/ml) was added 
and mixed and was immediately poured into gel 
tray and the comb was placed. After 
solidification of the gel, the comb was removed. 
The gel was placed in a horizontal 
electrophoresis apparatus filled with TAE 
buffer.   
Loading and electrophoresis of the 
sample 
Each 5 µl  of  isolated Plasmid DNA was  mixed  
with  1 µl  of 6X gel loading  buffer. The mixture 
was slowly loaded into the well using 
disposable micropipette tips. A marker of 1 Kb  
molecular  weight  was  loaded  in  one  well  to  
determine  the  size  of  the Plasmid DNA. 
Electrophoresis was carried out at 100 volts for 
1 hour. 
Visualization of the gel  
The amplified products of the study samples 
were visualized by using UV trans-illuminator. 
The  gel  was  photographed  by  a  digital  
camera  and  transferred  data  to the computer 
for further documentation . 
Results 
Identification and distribution of 
MRSA 
In this study different clinical samples were 
taken from out-patients and various wards of 
the KIST Medical College, Imadol, Kathmandu. 
For the identification of staphylococci, standard 
microbiological procedures were followed. This 
involves the morphological appearance of the 
isolated colony, staining reactions and 
biochemical properties. Each of the organisms 
was first isolated in pure form. Then colony 
morphology was noted, which was followed by 
Gram’s staining and biochemical tests. The 
detailed biochemical, cultural and staining 
techniques are mentioned in the supplementary 
section. Among all the clinical specimens 
processed during the study period, 414 
specimens showed positive growth among 
which 98 were isolated and identified as 
staphylococci by standard microbiological 
technique. The staphylococcal isolates were 
screened for S. aureus and coagulase-negative 
staphylococci by the coagulase test. Out of 98 
positive staphylococcal growths from different 
clinical specimens, 71 isolates were found to be 
coagulase-positive and were defined as S. aureus 
(Table 1). 
Out of 71 isolates of S. aureus, 27(38.02%) isolates 
were resistant to cefoxitin (<22 mm) and were 
defined as MRSA. Out of 27 MRSA isolates, 
highest number of MRSA was isolated from pus 
sample (n=8) followed by urine (n=8) and blood 
(n=7). However, only 2 MRSA was isolated from 
sputum specimens and only one from body 
fluids (Figure 1). 
Antibiotic susceptibility pattern of 
MRSA isolates 
We next determined the antibiotic susceptibility 
pattern of MRSA isolates. Here, we found that 
vancomycin and tetracycline (74.07%) were the 
most effective drugs whereas ampicillin 
(92.60%) and penicillin (92.60%) were least 
sensitive to MRSA isolates (Figure 2). 
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Figure 1: Distribution of MRSA in different 
clinical specimens. S. aureus were isolated from 
different clinical samples by standard 
microbiological techniques and were identified 
as MRSA by testing with cefoxitin discs having 
a zone of inhibition less than 22 mm. The 
number in the pie-chart indicates the number of 
MRSA isolated from different clinical 
specimens. S. aureus, Staphylococcus aureus; 
MRSA, methicillin-resistant S. aureus 
Plasmid Profiling of MRSA 
Twenty-seven isolates of MRSA isolated from 
various clinical samples were screened for 
plasmids. Out of these, 21 strains (77.77%) 
lacked any plasmid and 6 strains (22.22%) were 
detected with only one plasmid (Figure 3). The 
isolated plasmid and molecular weight of the 
plasmid can be visualized in the agarose gel 
shown in Figure 3. The plasmid profile of MRSA 
and plasmid profile with antimicrobial 
resistance patterns are shown in Table 2.  
 
Figure 3: Plasmid profile of MRSA. Plasmids 
were isolated by the alkaline-lysis method and 
were run in 1% agarose gel. Lane 1 and lane 18 
were loaded with 1 kb ladder, lane 6, 16, 24, 26, 
27 and 28 shows the positive samples with 
plasmid and are indicated by the red arrow. 
 
Figure 2: Antibiotic sensitivity patterns of MRSA isolates. Antibiotics sensitivity of MRSA was 
determined by the Kirby-Bauer disc diffusion method. The number in the graph indicates the 
percentage of the susceptibility of MRSA towards various tested antibiotics. 
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Table 2. Plasmid profiles and antimicrobial 
resistance of MRSA. Plasmids from MRSA 
were isolated by Alkaline-lysis method and 
antibiotic susceptibility patterns were 
determined by modified Kirby-Bauer disc 
diffusion method. Amp, ampicillin; AMC, 
amoxyclav; Cx, cefoxitin; COT, cotrimoxazole; 
Cip, ciprofloxacin; E, erythromycin; Ctx, 
cefotaxime; Gen, gentamycin;   Of, ofloxacin; P, 
penicillin; VA, vancomycin. 
 
Discussion 
In this study, cefoxitin disk was used for the 
detection of methicillin-resistant S. aureus. 
Oxacillin can also be used but the cefoxitin disk 
diffusion method is more effective in detecting 
hetero-resistant MRSA. Cefoxitin is also an 
inducer of the mecA gene hence suitable for 
detecting hetero-resistant MRSA. Furthermore, 
it gives a clearer endpoint and is easier to read 
than tests with oxacillin [22-24]. 
The present study revealed that the prevalence 
of MRSA was 38.02% from the total isolated S. 
aureus. The result of the present study correlates 
with the findings of the study conducted by 
Rajaduraipandi et al [25] where the prevalence 
of MRSA was 37.9% and with Sanjana et al [26] 
where 39.9% MRSA was isolated from different 
clinical samples. 
In developing countries like Nepal, screening of 
antibiotic susceptibility pattern of MRSA is a 
great tool for effective treatment and cost 
minimization. In this study, we determined the 
antibiotic susceptibility pattern of MRSA 
through the disc diffusion method. Here, we 
found that 92.60% of MRSA isolates were 
resistant to conventional drugs such as 
penicillin and ampicillin. Whereas, vancomycin 
and tetracycline were found to be the most 
effective drug as 85.19% of MRSA isolates 
showed sensitivity pattern. Thus, tetracycline 
can be considered as an alternative for 
vancomycin in the case of vancomycin resistant 
S. aureus.  
Plasmid profile has been reported as one of the 
techniques for typing MRSA [27]. Here, 27 
MRSA isolates were subjected to plasmid 
isolation by Alkaline-lysis method. Alkaline-
lysis in combination with the detergent SDS has 
been used for more than 20 years to isolate 
plasmid DNA from E. coli [28]. Exposure of 
bacterial isolates to strongly anionic detergent at 
high pH opens the cell wall, denatures 
chromosomal DNA and proteins and releases 
plasmid DNA into the supernatant. In this 
study, out of 27 MRSA isolates only 6 (22.22%) 
had plasmids. Plasmid profile analysis appears 
to be of very low discriminatory capacity in the 
investigation of MRSA epidemiology because of 
the non-detection of plasmids in the majority of 
the MRSA strains. This has been reported by 
Terry et al [29] and Ugbugo et al [30]. All 
plasmid-carrying strains harbored a single 
plasmid. This result was compatible with the 
study of Maithem et al [31] in which all the 
isolates harbored single plasmid. The 
acquisition of methicillin resistance is through a 
highly mobile genetic element, staphylococcal 
cassette chromosome (SCCmec) that carries 
mecA gene and confers methicillin resistance. A 
Study by Caddick et al [32] showed that the 
presence of plasmid DNA is involved in the 
acquisition of multi-drug resistance. However, 
there exists no significant correlation between 
plasmid DNA and multidrug-MRSA. This could 
be the possible reason for the low isolation of 
plasmid in our study. The molecular weights of 
the isolated plasmids were found to be more 
than ten thousand base pairs. This result was 
compatible with the study of Badger- Emeka et 
al [33] where all the isolates harbored plasmid 
with molecular weight ranging from 4969- 12130 
bp. All the MRSA strains which harbored the 
plasmid showed resistance towards β-lactam 
antibiotics such as cefoxitin, penicillin, and 
ampicillin. This was also similar to Badger- 
Emeka et al [33] where plasmid harbored strains 
had more resistance towards β-lactam 
antibiotics. Thus, it might be concluded that the 
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resistance of MRSA towards β- lactam 
antibiotics was plasmid-mediated. 
The detection of mecA gene or penicillin-binding 
protein 2a is considered as a more reliable and 
confirmatory method for identifying MRSA 
[34]. Furthermore, plasmid profiling along with 
antibiotic susceptibility patters are considered 
as a useful method for epidemiological studies 
and to design antibiotic policies and effective 
control measures [27, 31]. In this study, we 
determined the prevalence of MRSA in different 
clinical specimens along with their antibiotic 
susceptibility pattern and plasmid profiling. 
However, the determination of mecA gene 
should be done to confirm MRSA isolates and 
are limited in this study. The result of this study 
concluded that there is a great need of regular 
surveillance in order to monitor resistance 
patterns and minimize the increase of antibiotic-
resistant micro-organisms. 
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